Clinical Trial Update: 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

This Phase 4 trial compares two years of teriparatide therapy to one year of teriparatide followed by one year of raloxifene or calcium/vitamin D in women with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Calcium + Vitamin D supplement (calcium/vitamin D)
• Forteo (teriparatide)
• Raloxifene (raloxifene)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED